Lv2
146 积分 2025-06-11 加入
A novel MYO5C–ALK fusion in lung adenocarcinoma: limited alectinib response and durable lorlatinib benefit
22小时前
已完结
Approach to the patient: Oncocytic thyroid cancer
1个月前
已完结
Acral Lentiginous Melanoma Harboring a ROS1 Gene Fusion With Clinical Response to Entrectinib
1个月前
已完结
Acral Lentiginous Melanoma Harboring a ROS1 Gene Fusion With Clinical Response to Entrectinib
2个月前
已完结
Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
3个月前
已完结
Approach to the patient: Oncocytic thyroid cancer
3个月前
已完结
Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer
3个月前
已完结
Clinical application of circulating tumour DNA in colorectal cancer
3个月前
已完结
The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF‐κB pathway
3个月前
已完结
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations
3个月前
已完结
皖公网安备34019202002308
